Lisa Kitasato
Sagamihara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Canagliflozin restores electrical properties and suppresses structural damage in isoproterenol-induced myocardial injury models.
Journal: Scientific reports
Published: April 16, 2025
The Role of Esaxerenone in the Continuum of Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Observational Study.
Journal: Clinical cardiology
Published: July 20, 2024
Rivaroxaban as a Protector of Oxidative Stress-Induced Vascular Endothelial Glycocalyx Damage via the IQGAP1/PAR1-2/PI3K/Akt Pathway.
Journal: Journal of vascular research
Published: June 20, 2024
Association between instrumental activities of daily living frequency and clinical outcomes in older patients with cardiovascular disease.
Journal: European journal of cardiovascular nursing
Published: October 31, 2021
Design of Functional Electrospun Scaffolds Based on Poly(glycerol sebacate) Elastomer and Poly(lactic acid) for Cardiac Tissue Engineering.
Journal: ACS biomaterials science & engineering
Published: January 18, 2021
Lower Level of Low Density Lipoprotein Cholesterol is Associated with a Higher Increase in the Fractional Flow Reserve in Patients with Fixed-dose Rosuvastatin.
Journal: Journal of atherosclerosis and thrombosis
Published: August 22, 2017
Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation.
Journal: Heart and vessels
Published: March 19, 2017
Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation.
Journal: Heart and vessels
Published: July 13, 2016
Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth.
Journal: Nature communications
Published: May 03, 2016
Last Updated: 09/26/2026